Log in to save to my catalogue

Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic re...

Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_da1d37ab9b684356a8d44480e76143bc

Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance

About this item

Full title

Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance

Author / Creator

Publisher

England: BioMed Central Ltd

Journal title

Clinical proteomics, 2011-07, Vol.8 (1), p.12-12, Article 12

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Enzymes are critically important in the transportation, metabolism, and clearance of most therapeutic drugs used in clinical practice today. Many of these enzymes have significant genetic polymorphisms that affect the enzyme's rate kinetics. Regarding drug metabolism, specific polymorphisms to the cytochrome (CYP) P450 enzyme family are linked to p...

Alternative Titles

Full title

Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_da1d37ab9b684356a8d44480e76143bc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_da1d37ab9b684356a8d44480e76143bc

Other Identifiers

ISSN

1542-6416,1559-0275

E-ISSN

1559-0275

DOI

10.1186/1559-0275-8-12

How to access this item